About the book
The recent emergence of a novel, pathogenic coronavirus known as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, officially COVID-19) and its subsequent rapid spread across the world has put the global health at risk. The ongoing efforts are focused on gaining insights into the epidemiology along with the discovered genome structure and important viral factors of SARS-CoV-2. Biotechnology-based innovative solutions are being sought to develop new rapid methods including point-of-care diagnostics and surveillance technologies to detect SARS-CoV-2 early in order to control the disease and mitigate it in a timely fashion. These efforts have also focused on investigating therapeutics including significant breakthroughs in clinical trials on antiviral drugs and vaccines to alleviate the challenges of COVID-19.
This book intends to provide a comprehensive overview of the current state-of-the-art in epidemiology, transmission and genome structure along with the latest breakthroughs in diagnostics, therapeutics and vaccines to combat COVID-19.